they may have refused the offer, but they are asking
-gsk- to participate with the evaluation being conducted.
which means, they want to sell to -gsk-, but they want
what the company is worth.
-gsk- is taking advantage of -hgsi- weakness in the market,
and " low balling " them, and they know it!
mrk/pfe/bmy/lly/jnj/abt/-- could come in and knock
-gsk- right out of the saddle if they so chose too!! all
of these companies compete against each other. it would
not surprise me if one of them do, just to piss -gsk- off.
all of them have the capital to do so, and not even miss
the money. " just a thought "
" I COULD BE WRONG "